Business ❯ Pharmaceutical Industry

Mergers and Acquisitions

Market Trends Sanofi Financial Transactions Verona Pharma Gilead Sciences Jazz Pharmaceuticals Pfizer Drug Development Market Competition CinCor Pharma Merck Bristol Myers Squibb Generic Drug Market Corporate Strategy AstraZeneca Acquisitions Servier Contract Manufacturing AstraZeneca

Novartis Strikes $2 Billion Deal for Mutant-Selective PI3Kα Cancer Drug SNV4818

The Phase 1/2 asset targets PIK3CA‑mutant tumors to improve tolerability in HR+/HER2‑ breast cancer with closing expected in the first half of 2026.

Servier to Acquire Day One Biopharma in $2.5 Billion All-Cash Deal at $21.50 a Share

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case